The previous page is sending you to https://www.globenewswire.com/news-release/2019/11/14/1947573/0/en/Ascendis-Pharma-Expands-TransCon-PTH-Phase-2-PaTH-Forward-Clinical-Trial-to-Expedite-Enrollment-of-Subjects-Previously-Treated-with-NATPARA-in-the-United-States.html.

 If you do not want to visit that page, you can return to the previous page.